Paris (France) and Lausanne (Switzerland), 26 June 2009
Azzalure approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
This market authorisation is part of a process including 15 countries in Europe. Azzalure® will be commercialised in Germany by Galderma.
This market authorisation is part of a process including 15 countries in Europe. Azzalure® will be commercialised in Germany by Galderma.
Paris (France), 15 June 2009
Ipsen and PHARNEXT conclude an exclusive research, development and marketing agreement
The agreement concerns innovative drug candidates issued from the Pleotherapy™ technology intended for the treatment of Charcot-Marie-Tooth disease
The agreement concerns innovative drug candidates issued from the Pleotherapy™ technology intended for the treatment of Charcot-Marie-Tooth disease
Paris (France), 10 June 2009
20th Neuronal Plasticity Prize awarded to three eminent scientists for their research into the domain of the brain-machine interaction: Alim-Louis Benabid, Apostolos P. Georgopoulos and Miguel A. L. Nicolelis
The 20th annual Neuronal Plasticity Prize has been awarded to Alim-Louis Benabid (CEA Minatec LETI,Grenoble, France), Apostolos P. Georgopoulos (University of Minnesota, Minneapolis, USA) and Miguel A. L. Nicolelis (Duke University, Durham, USA) for their research in the domain of the brain-machine interaction.
The 20th annual Neuronal Plasticity Prize has been awarded to Alim-Louis Benabid (CEA Minatec LETI,Grenoble, France), Apostolos P. Georgopoulos (University of Minnesota, Minneapolis, USA) and Miguel A. L. Nicolelis (Duke University, Durham, USA) for their research in the domain of the brain-machine interaction.
